• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Ventas Announces Pricing of Senior Notes Offering

    5/29/25 5:31:00 PM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate
    Get the next $VTR alert in real time by email

    Ventas, Inc. (NYSE:VTR) ("Ventas" or the "Company") announced today that its wholly owned subsidiary, Ventas Realty, Limited Partnership ("Ventas Realty"), has priced an underwritten public offering of $500 million aggregate principal amount of 5.100% Senior Notes due 2032 (the "Notes") at an issue price equal to 99.391% of the principal amount of the Notes. The Notes will be senior unsecured obligations of Ventas Realty and will be fully and unconditionally guaranteed by the Company and will mature on July 15, 2032. The sale of the Notes is expected to close on June 3, 2025, subject to the satisfaction of customary closing conditions.

    The Company intends to use the proceeds from the offering of the Notes for general corporate purposes, which may include repayment of other indebtedness, or any other general corporate purposes the Company may deem necessary or advisable, and to pay fees and expenses related to the offering of the Notes.

    BofA Securities, Inc., BNP Paribas Securities Corp., J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC are acting as joint book-running managers for the offering of the Notes.

    The Company and Ventas Realty have filed a registration statement (including a prospectus) and a preliminary prospectus supplement with the Securities and Exchange Commission (the "SEC") for the offering of the Notes to which this communication relates. Before you invest, you should read the preliminary prospectus supplement, the accompanying prospectus in that registration statement and the other documents the Company and Ventas Realty have filed with the SEC for more complete information about the Company, Ventas Realty and this offering. You may get these documents for free by visiting EDGAR on the SEC's website at www.sec.gov. Alternatively, the Company, Ventas Realty, any underwriter or any dealer participating in the offering will arrange to send you the preliminary prospectus supplement and the accompanying prospectus if you request it by contacting: BofA Securities, Inc. at 1-800-294-1322, BNP Paribas Securities Corp. at 1-800-854-5674, J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 or by email at [email protected] and [email protected] or from Morgan Stanley & Co. LLC toll-free at 1-866-718-1649.

    This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sales of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.

    About Ventas

    Ventas, Inc. (NYSE:VTR) is a leading S&P 500 real estate investment trust enabling exceptional environments that benefit a large and growing aging population. With approximately 1,400 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company's growth is fueled by its approximately 850 senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. Ventas aims to deliver outsized performance by leveraging its operational expertise, data-driven insights from its Ventas OITM platform, extensive relationships and strong financial position. The Ventas portfolio also includes outpatient medical buildings, research centers and healthcare facilities. Ventas's seasoned team of talented professionals shares a commitment to excellence, integrity and a common purpose of helping people live longer, healthier, happier lives.

    Safe Harbor Statement

    This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include, among others, statements of expectations, beliefs, future plans and strategies, anticipated results from operations and developments and other matters that are not historical facts. Forward-looking statements include, among other things, statements regarding our and our officers' intent, belief or expectation as identified by the use of phrases or words such as "assume," "may," "will," "project," "expect," "believe," "intend," "anticipate," "seek," "target," "forecast," "plan," "potential," "could," "would," "should" and other comparable and derivative terms or the negatives thereof.

    Forward-looking statements are based on management's beliefs as well as on a number of assumptions concerning future events. You should not put undue reliance on these forward-looking statements, which are not a guarantee of performance and are subject to a number of uncertainties and other factors that could cause actual events or results to differ materially from those expressed or implied by the forward-looking statements. We do not undertake a duty to update these forward-looking statements, which speak only as of the date on which they are made. We urge you to carefully review the disclosures we make concerning risks and uncertainties that may affect our business and future financial performance, including those made below and in our filings with the Securities and Exchange Commission, such as in the sections titled "Cautionary Statements — Summary Risk Factors," "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our Annual Report on Form 10-K for the year ended December 31, 2024 and our subsequent Quarterly Report on Form 10-Q.

    Certain factors that could affect our future results and our ability to achieve our stated goals include, but are not limited to: (a) our exposure and the exposure of our managers, tenants and borrowers to complex and evolving governmental policy, laws and regulations, including relating to healthcare, data privacy, cybersecurity, international trade and environmental matters, the impact of such policies, laws and regulations on our and our managers', tenants' and borrowers' business and the challenges and expense associated with complying with such policies, laws and regulations; (b) the impact of market, macroeconomic, general economic conditions and fiscal policy on us, our managers, tenants and borrowers and in areas in which our properties are geographically concentrated, including changes in or elevated inflation, interest rates and exchange rates, labor market dynamics and rises in unemployment, tightening of lending standards and reduced availability of credit or capital, events that affect consumer confidence, our occupancy rates and resident fee revenues, and the actual and perceived state of the real estate markets and public and private capital markets; (c) the potential for significant general and commercial claims, legal actions, investigations, regulatory proceedings and enforcement actions that could subject us or our managers, tenants or borrowers to increased operating costs, uninsured liabilities, including fines and other penalties, reputational harm or significant operational limitations, including the loss or suspension of or moratoriums on accreditations, licenses or certificates of need, suspension of or nonpayment for new admissions, denial of reimbursement, suspension, decertification or exclusion from federal, state or foreign healthcare programs or the closure of facilities or communities; (d) our reliance on third-party managers and tenants to operate or exert substantial control over properties they manage for, or rent from, us, which limits our control and influence over such properties, their operations and their performance; (e) our reliance and the reliance of our managers, tenants and borrowers on the financial, credit and capital markets and the risk that those markets may be disrupted or become constrained; (f) our ability, and the ability of our managers, tenants and borrowers, to navigate the trends impacting our or their businesses and the industries in which we or they operate, including their ability to respond to the impact of the U.S. political environment on government funding and reimbursement programs, and the financial condition or business prospect of our managers, tenants and borrowers; (g) our ability to achieve the anticipated benefits and synergies from, and effectively integrate, our completed or anticipated acquisitions and investments; (h) the risk of bankruptcy, inability to obtain benefits from governmental programs, insolvency or financial deterioration of our managers, tenants borrowers and other obligors which may, among other things, have an adverse impact on the ability of such parties to make payments or meet their other obligations to us, which could have an adverse impact on our results of operations and financial condition; (i) the risk that the borrowers under our loans or other investments default or that, to the extent we are able to foreclose or otherwise acquire the collateral securing our loans or other investments, we will be required to incur additional expense or indebtedness in connection therewith, that the assets will underperform expectations or that we may not be able to subsequently dispose of all or part of such assets on favorable terms; (j) our current and future amount of outstanding indebtedness, and our ability to access capital and to incur additional debt which is subject to our compliance with covenants in instruments governing our and our subsidiaries' existing indebtedness; (k) risks related to the recognition of reserves, allowances, credit losses or impairment charges which are inherently uncertain and may increase or decrease in the future and may not represent or reflect the ultimate value of, or loss that we ultimately realize with respect to, the relevant assets, which could have an adverse impact on our results of operations and financial condition; (l) the risk that our management agreements or leases are not renewed or are renewed on less favorable terms, that our managers or tenants default under those agreements or that we are unable to replace managers or tenants on a timely basis or on favorable terms, if at all; (m) our ability to identify and consummate future investments in, or dispositions of, healthcare assets and effectively manage our portfolio opportunities and our investments in co-investment vehicles, joint ventures and minority interests, including our ability to dispose of such assets on favorable terms as a result of rights of first offer or rights of first refusal in favor of third parties; (n) risks related to development, redevelopment and construction projects, including costs associated with inflation, rising or elevated interest rates, labor conditions and supply chain pressures, and risks related to increased construction and development in markets in which our properties are located, including adverse effect on our future occupancy rates; (o) our ability to attract and retain talented employees; (p) the limitations and significant requirements imposed upon our business as a result of our status as a REIT and the adverse consequences (including the possible loss of our status as a REIT) that would result if we are not able to comply with such requirements; (q) the ownership limits contained in our certificate of incorporation with respect to our capital stock in order to preserve our qualification as a REIT, which may delay, defer or prevent a change of control of our company; (r) increases in our borrowing costs as a result of becoming more leveraged, including in connection with acquisitions or other investment activity and rising or elevated interest rates; (s) our exposure to various operational risks, liabilities and claims from our operating assets; (t) our dependency on a limited number of managers and tenants for a significant portion of our revenues and operating income; (u) our exposure to particular risks due to our specific asset classes and operating markets, such as adverse changes affecting our specific asset classes and the healthcare real estate sector, the competitiveness or financial viability of hospitals on or near the campuses where our outpatient medical buildings are located, our relationships with universities, the level of expense and uncertainty of our research tenants, and the limitation of our uses of some properties we own that are subject to ground lease, air rights or other restrictive agreements; (v) our ability to maintain a positive reputation for quality and service with our key stakeholders; (w) the availability, adequacy and pricing of insurance coverage provided by our policies and policies maintained by our managers, tenants, borrowers or other counterparties; (x) the risk of exposure to unknown liabilities from our investments in properties or businesses; (y) the occurrence of cybersecurity threats and incidents that could disrupt our or our managers', tenants' or borrower's operations, result in the loss of confidential or personal information or damage our business relationships and reputation; (z) the failure to maintain effective internal controls, which could harm our business, results of operations and financial condition; (aa) the impact of merger, acquisition and investment activity in the healthcare industry or otherwise affecting our managers, tenants or borrowers; (bb) disruptions to the management and operations of our business and the uncertainties caused by activist investors; (cc) the risk of catastrophic or extreme weather and other natural events and the physical effects of climate change; (dd) the risk of potential dilution resulting from future sales or issuances of our equity securities; and (ee) the other factors set forth in our periodic filings with the Securities and Exchange Commission.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250529911010/en/

    Ventas, Inc.

    BJ Grant

    (877) 4-VENTAS

    Get the next $VTR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $VTR

    DatePrice TargetRatingAnalyst
    3/7/2025Hold → Buy
    Argus
    1/17/2025$66.00 → $65.00Neutral → Outperform
    Robert W. Baird
    10/1/2024$61.00 → $71.00Equal Weight → Overweight
    Wells Fargo
    3/18/2024$50.00In-line → Outperform
    Evercore ISI
    2/26/2024$52.00 → $46.00Overweight → Equal Weight
    Wells Fargo
    1/30/2024$60.00Buy
    Deutsche Bank
    1/16/2024$48.00 → $53.00Neutral → Buy
    BofA Securities
    11/7/2023$44.00 → $51.00Neutral → Outperform
    Wedbush
    More analyst ratings

    $VTR
    SEC Filings

    See more
    • SEC Form FWP filed by Ventas Inc.

      FWP - Ventas, Inc. (0000740260) (Subject)

      5/29/25 5:20:02 PM ET
      $VTR
      Real Estate Investment Trusts
      Real Estate
    • SEC Form 144 filed by Ventas Inc.

      144 - Ventas, Inc. (0000740260) (Subject)

      5/21/25 5:41:55 PM ET
      $VTR
      Real Estate Investment Trusts
      Real Estate
    • SEC Form SCHEDULE 13G filed by Ventas Inc.

      SCHEDULE 13G - Ventas, Inc. (0000740260) (Subject)

      5/13/25 12:29:04 PM ET
      $VTR
      Real Estate Investment Trusts
      Real Estate

    $VTR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Ventas Inc.

      SC 13G - Ventas, Inc. (0000740260) (Subject)

      10/15/24 1:39:07 PM ET
      $VTR
      Real Estate Investment Trusts
      Real Estate
    • SEC Form SC 13G/A filed by Ventas Inc. (Amendment)

      SC 13G/A - Ventas, Inc. (0000740260) (Subject)

      2/13/24 5:16:09 PM ET
      $VTR
      Real Estate Investment Trusts
      Real Estate
    • SEC Form SC 13G filed by Ventas Inc.

      SC 13G - Ventas, Inc. (0000740260) (Subject)

      2/9/24 10:05:20 AM ET
      $VTR
      Real Estate Investment Trusts
      Real Estate

    $VTR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Ventas upgraded by Argus

      Argus upgraded Ventas from Hold to Buy

      3/7/25 8:20:28 AM ET
      $VTR
      Real Estate Investment Trusts
      Real Estate
    • Ventas upgraded by Robert W. Baird with a new price target

      Robert W. Baird upgraded Ventas from Neutral to Outperform and set a new price target of $65.00 from $66.00 previously

      1/17/25 7:52:13 AM ET
      $VTR
      Real Estate Investment Trusts
      Real Estate
    • Ventas upgraded by Wells Fargo with a new price target

      Wells Fargo upgraded Ventas from Equal Weight to Overweight and set a new price target of $71.00 from $61.00 previously

      10/1/24 7:53:59 AM ET
      $VTR
      Real Estate Investment Trusts
      Real Estate

    $VTR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • EVP and GC Roberts Carey S. sold $1,509,447 worth of shares (23,500 units at $64.23), decreasing direct ownership by 17% to 116,650 units (SEC Form 4)

      4 - Ventas, Inc. (0000740260) (Issuer)

      5/30/25 5:24:44 PM ET
      $VTR
      Real Estate Investment Trusts
      Real Estate
    • EVP and CFO Probst Robert F exercised 17,374 shares at a strike of $62.22 and sold $1,133,139 worth of shares (17,374 units at $65.22) (SEC Form 4)

      4 - Ventas, Inc. (0000740260) (Issuer)

      5/29/25 5:05:17 PM ET
      $VTR
      Real Estate Investment Trusts
      Real Estate
    • EVP and CFO Probst Robert F sold $4,495,212 worth of shares (69,592 units at $64.59) and exercised 33,592 shares at a strike of $53.79, decreasing direct ownership by 18% to 168,364 units (SEC Form 4)

      4 - Ventas, Inc. (0000740260) (Issuer)

      5/23/25 5:00:30 PM ET
      $VTR
      Real Estate Investment Trusts
      Real Estate

    $VTR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Ventas Announces Pricing of Senior Notes Offering

      Ventas, Inc. (NYSE:VTR) ("Ventas" or the "Company") announced today that its wholly owned subsidiary, Ventas Realty, Limited Partnership ("Ventas Realty"), has priced an underwritten public offering of $500 million aggregate principal amount of 5.100% Senior Notes due 2032 (the "Notes") at an issue price equal to 99.391% of the principal amount of the Notes. The Notes will be senior unsecured obligations of Ventas Realty and will be fully and unconditionally guaranteed by the Company and will mature on July 15, 2032. The sale of the Notes is expected to close on June 3, 2025, subject to the satisfaction of customary closing conditions. The Company intends to use the proceeds from the offe

      5/29/25 5:31:00 PM ET
      $VTR
      Real Estate Investment Trusts
      Real Estate
    • Ventas Issues Business Update and Will Present at Nareit's REITweek 2025 Investor Conference

      In conjunction with upcoming investor meetings, Ventas, Inc. (NYSE:VTR) (the "Company," "Ventas") has issued a business update, which is available on the Company's website. In addition, the Company announced today that management will make a presentation at Nareit's REITweek 2025 Investor Conference (the "Nareit Conference") on June 3, 2025, at 1:45 p.m. Eastern Time. The business update and Nareit Conference webcast and materials will be accessible on the Company's website at ir.ventasreit.com/events-and-presentations for a limited period. About Ventas Ventas, Inc. (NYSE:VTR) is a leading S&P 500 real estate investment trust enabling exceptional environments that benefit a large an

      5/28/25 8:30:00 AM ET
      $VTR
      Real Estate Investment Trusts
      Real Estate
    • Ventas Declares Quarterly Dividend of $0.48 Per Common Share

      Ventas, Inc. (NYSE:VTR) today announced that its Board of Directors has declared a quarterly dividend of $0.48 per common share. The dividend will be payable in cash on July 17, 2025 to stockholders of record as of the close of business on June 30, 2025. About Ventas Ventas, Inc. (NYSE:VTR) is a leading S&P 500 real estate investment trust enabling exceptional environments that benefit a large and growing aging population. With approximately 1,400 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company's growth is fueled by its approximately 850 senior housing communities, which provide valuable services to residents and

      5/13/25 5:07:00 PM ET
      $VTR
      Real Estate Investment Trusts
      Real Estate

    $VTR
    Leadership Updates

    Live Leadership Updates

    See more
    • Land & Buildings Issues Letter to Shareholders of National Health Investors Announcing its Intention to Vote Against Two Directors at 2024 Annual Meeting

      Believes NHI is Significantly Undervalued with Opportunities to Unlock its Valuable Assets, Including Upcoming Lease Renewal with Tenant National Healthcare Corporation Highlights Poor Corporate Governance and Serious Conflicts of Interest Among Board Members Expresses Serious Concerns that NHI Board Cannot Fairly Represent Both Landlord and Tenant in Lease Renegotiation Given Substantial Economic and Personal Ties to NHC Discloses Likely Substantial Upside to Lease Rental Rates if Lease is Negotiated at Arms-Length Believes Shareholders Need to Send a Clear Message at Upcoming Annual Meeting – Ahead of Critical Lease Renegotiations – that Maintaining the Status Quo is Not an Option

      4/18/24 9:15:00 AM ET
      $NHC
      $NHI
      $SUI
      $VTR
      Hospital/Nursing Management
      Health Care
      Real Estate Investment Trusts
      Real Estate
    • Ventas Appoints Theodore Bigman and Joe V. Rodriguez, Jr. to Board of Directors

      Enters Into Cooperation Agreement with Land & Buildings Ventas, Inc. (NYSE:VTR) today announced that its Board of Directors has appointed Theodore Bigman and Joe V. Rodriguez, Jr. to the Board, effective immediately. In connection with the appointments, which align with Ventas's ongoing focus on Board refreshment and maintaining strong governance, the Company has entered into a mutual cooperation agreement (the "Cooperation Agreement") with shareholder Land & Buildings Investment Management LLC ("Land & Buildings"). Mr. Bigman brings significant investing and capital markets experience, and has served as a private investor and as founder and Chief Investment Officer of Bigman Holdings,

      3/4/24 8:03:00 AM ET
      $VTR
      Real Estate Investment Trusts
      Real Estate
    • Ardent Announces Senior Leadership Appointments and Promotions

      Ardent Health Services today announced the appointment of two new senior operations leaders and the promotion of three executives to expanded roles. Mike Matthews has been appointed president of Ardent Physician Services. He will oversee Ardent's medical group operations across eight markets in six states while working closely with providers to create greater alignment across the continuum of care. Matthews was previously senior vice president at ScionHealth where he led the company's physician enterprise, which included more than 500 providers across 13 states. Prior to that, he served as regional vice president of physician services for Lifepoint Health. David Schultz has been named p

      4/12/23 10:00:00 AM ET
      $VTR
      Real Estate Investment Trusts
      Real Estate

    $VTR
    Financials

    Live finance-specific insights

    See more
    • Ventas Declares Quarterly Dividend of $0.48 Per Common Share

      Ventas, Inc. (NYSE:VTR) today announced that its Board of Directors has declared a quarterly dividend of $0.48 per common share. The dividend will be payable in cash on July 17, 2025 to stockholders of record as of the close of business on June 30, 2025. About Ventas Ventas, Inc. (NYSE:VTR) is a leading S&P 500 real estate investment trust enabling exceptional environments that benefit a large and growing aging population. With approximately 1,400 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company's growth is fueled by its approximately 850 senior housing communities, which provide valuable services to residents and

      5/13/25 5:07:00 PM ET
      $VTR
      Real Estate Investment Trusts
      Real Estate
    • Ventas Reports 2025 First Quarter Results

      Ventas, Inc. (NYSE:VTR) ("Ventas" or the "Company") today reported results for the first quarter ended March 31, 2025. CEO Remarks "Ventas delivered a strong first quarter of 2025, as we executed on our strategy to capitalize on the unprecedented multiyear growth opportunity in senior housing. We drove double-digit growth in our senior housing operating portfolio (SHOP), which powered our first quarter results," said Debra A. Cafaro, Ventas Chairman and CEO. "Already this year, we have completed nearly all of our original billion-dollar investment guidance in attractive SHOP investments designed to increase our forward enterprise growth rate. Our investment pipeline continues to grow and

      4/30/25 4:10:00 PM ET
      $VTR
      Real Estate Investment Trusts
      Real Estate
    • Ventas Announces First Quarter 2025 Earnings Release Date and Conference Call

      Ventas, Inc. (NYSE:VTR) will issue its first quarter 2025 earnings release after the close of trading on the New York Stock Exchange on Wednesday, April 30, 2025. A conference call to discuss those earnings will be held on Thursday, May 1, 2025 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The dial-in number for the conference call is (888) 330-3576 (or +1 (646) 960-0672 for international callers), and the participant passcode is 7655497. A live webcast can be accessed from the Investor Relations section of www.ventasreit.com. A telephonic replay will be available at (800) 770-2030 (or +1 (609) 800-9909 for international callers), passcode 7655497, after the earnings call and will

      4/4/25 4:18:00 PM ET
      $VTR
      Real Estate Investment Trusts
      Real Estate